Profile for Halozyme Therapeutics Inc. (HALO)

$ 30.83   -0.27 (-0.87%) Volume: 1.71m 4:00 PM EDT 26-Oct-2020
After Hours:  $ 31.295   0.465 (+1.51%) Volume: 142.48k 6:27 PM EDT 26-Oct-2020
Business Description:
Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.
Address: 11388 Sorrento Valley Road, San Diego, CA, US, 92121
Telephone: +1 858 794-8889 Website:
Facsimile: +1 858 704-8311 Email: [email protected]
CEO: Helen I. Torley
Employees: 132 Market Cap: 4.22b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1159036
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)